Ikonisys SA announced it has secured a financing program that could reach an aggregate nominal amount of €6 million with Negma Group, an institutional investment fund headquartered in Dubai, UAE, in the form of bonds convertible into new shares, with a par value of €2,500 each, with attached share subscription warrants. This financing can be drawn down in several tranches for the next 2 years, without any obligation to do so. The purpose of this funding program is to provide the Company with additional resources to accelerate its commercialization strategy in the United States and Europe, including additional marketing investments, new
contacts with KOLs who will serve as reference laboratories, participation in conferences and the implementation of a distribution strategy with agreements for Spain, Portugal, Eastern Europe, the Middle East and Latin
America, and to continue the development of the Ikoniscope20. The Issuer's board of directors approved the entry into this financing program in its meeting dated May 4, 2022. The securities to be issued in the framework of this financing agreement will give access to the Issuer's share capital with cancellation of the shareholders' preferential subscription rights. Such securities will be issued on the basis of the 8th resolution of the general meeting of the shareholders of Ikonisys dated June 15, 2021. This financing program will not require the approval of a prospectus by the AMF. Main characteristics of the OCA. The OCA will be issued in several tranches of €300,000 of nominal amount each, being specified that the Issuer shall be allowed to issue up to three tranches of €500,000 of nominal amount each, at its sole discretion. The tranches of OCABSA will be issued upon request of the Issuer, subject to standard conditions precedent described in Note 1 and no earlier tha the trading day following the conversion of all the OCA that had been issued in connection with a previous tranche; or the expiry of a period of 24 trading days from the drawdown of any tranche of an aggregate principal amount of EUR 300,000 or 40 trading days from the drawdown of any tranche of an aggregate principal amount of EUR 500,000. The OCA will have a par value of €2,500. The subscription price of each OCA will be equal to their par value. The OCA will be freely transferable to affiliates of the Investor. The OCA will not be listed or admitted to trading on a financial market. The OCA will not bear interest and will have a 12 months maturity period from their date of issuance. Holders of OCA may request at any time to convert them until their maturity date. On their maturity date, and if the OCA have not been converted yet, the OCA will be automatically converted into new shares on the maturity date. Upon occurrence of an event of default, unconverted OCA may be redeemed by the Issuer, upon request of the Investor, at their nominal amount. The Issuer shall have the right to buy-back any OCA outstanding at their par value at any time.